Publications by authors named "Otfried Debus"

Claim this Profile
C
Characterization of the Epileptogenic Phenotype and Response to Antiseizure Medications in Lissencephaly Patients.
Christiane R Proepper, Sofia M Schuetz, Lisa-Maria Schwarz, Katja von Au, Thomas Bast, Otfried Debus

Neuropediatrics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplerotic Therapy Using Triheptanoin in Two Brothers Suffering from Aconitase 2 Deficiency.
Maximilian Penkl, Johannes A Mayr, René G Feichtinger, Ralf Reilmann, Otfried Debus

Metabolites· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History and Developmental Trajectories of Individuals With Disease-Causing Variants in .
Kim M Thalwitzer, Jan H Driedger, Julie Xian, Afshin Saffari, Pia Zacher, Otfried M Debus

Neurology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutation in the neonatal isoform of SCN2A causes neonatal-onset epilepsy.
Anja Penkl, Janine Reunert, Otfried M Debus, Anna Homann, Ulrike Och

Am J Med Genet A· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Music Therapy Supports Children with Neurological Diseases during Physical Therapy Interventions.
Susann Kobus, Franziska Bologna, Ines Maucher, Daniel Gruenen, Ramona Brandt, Otfried Debus

Int J Environ Res Public Health· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Translational Medicine Professional: A Bridge Between Bench and Bedside?
Faekah Gohar, Aisha Gohar, Georg Hülskamp, Otfried Debus

Front Med (Lausanne)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIS1-associated classic lissencephaly: A retrospective, multicenter survey of the epileptogenic phenotype and response to antiepileptic drugs.
Saskia M Herbst, Christiane R Proepper, Tobias Geis, Ingo Borggraefe, Andreas Hahn, Otfried Debus

Brain Dev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The earlier, the better].
Birgit Batenhorst, Heriburg Hidding, Otfried Debus

Kinderkrankenschwester· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations.
Siddharth Banka, Christian de Goede, Wyatt W Yue, Andrew A M Morris, Beate von Bremen, Otfried Debus

Mol Genet Metab· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P50 sensory gating deficit in children with centrotemporal spikes and sharp waves in the EEG.
Barbara J Fiedler, Otfried M Debus, Bernd A Neubauer, Matthias Kienle, Gerhard Kurlemann

Neurosci Lett· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital disorder of glycosylation type Id: clinical phenotype, molecular analysis, prenatal diagnosis, and glycosylation of fetal proteins.
Jonas Denecke, Christian Kranz, Juergen Ch von Kleist-Retzow, Kristin Bosse, Peter Herkenrath, Otfried Debus

Pediatr Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and subacute intracerebral hemorrhages: comparison of MR imaging at 1.5 and 3.0 T--initial experience.
Thomas Allkemper, Bernd Tombach, Wolfram Schwindt, Harald Kugel, Matthias Schilling, Otfried Debus

Radiology· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The factor V G1691A mutation is a risk for porencephaly: A case-control study.
Otfried M Debus, Andrea Kosch, Ronald Sträter, Rainer Rossi, Ulrike Nowak-Göttl

Ann Neurol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication.
Otfried Martin Debus, Gerhard Kurlemann,

Epilepsia· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study.
Otfried M Debus, Alexander Lerchl, Hans W Bothe, Janbernd Bremer, Barbara Fiedler

J Pineal Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on treatment with pyridoxine and sulthiame in 12 infants with West syndrome: an open clinical study.
Otfried Martin Debus, Jessika Köhring, Barbara Fiedler, Maike Franssen, Gerhard Kurlemann

Seizure· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis